MedPath
NMPA Approval

Luspatercept for Injection

国药准字SJ20220002

celgene corporation, a bristol-myers squibb company

January 25, 2022

Drug Information

注射用罗特西普

利布洛泽

注射剂

25mg

生物制品

January 25, 2022

January 24, 2027

Company Information

Applicant Company

celgene corporation, a bristol-myers squibb company

Route 206 and Province Line Road, Princeton, NJ 08543 United States of America

Manufacturing Company

PATHEON ITALIA SPA

Viale Gian Battista Stucchi 110, Monza 20900 Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用罗特西普 - NMPA 批准文号 | MedPath